Horizon Discovery signs collaboration and license agreement with Mammoth Biosciences
January 13, 2020
Aims to develop the next generation of engineered CHO cell lines, to improve production of biotherapeutics Bioproduction is a key business unit within Horizon, this agreement underlines strategy to focus on core markets Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Group”), a global leader in the application of gene editing and [...]
January 13, 2020
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. The NextSeq 2000 Sequencing System — The latest NGS system from Illumina [...]
January 13, 2020
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Collaborations With Guardant Health and QIAGEN Will Develop Blood- and Tissue-Based Companion Diagnostics For Investigational KRAS(G12C) Inhibitor AMG 510 KRAS G12C is Present in 13% of Non-Small Cell Lung Cancers With no Approved Targeted Treatments THOUSAND OAKS, Calif. -- Amgen (NASDAQ: AMGN) today announced [...]
Statement: MGI is committed to protecting its intellectual property assets on a global scale
January 11, 2020
MGI makes the following statement in response to Illumina's patent litigation in the UK and Sweden: We believe these claims have no merit and are typical Illumina tactics intended to maintain a monopolistic market position and prevent choice from being offered to customers. We intend to vigorously defend ourselves, as we have in other jurisdictions. [...]
QIAGEN celebrates surpassing 2,500 cumulative placements of QIAsymphony
January 10, 2020
• Milestone instrument placed with Cenata GmbH in Germany • More than 30 diagnostic assays, including eight FDA approved tests available for the system • Launch of new PowerFecal Pro Kit automating microbiome sample preparation Hilden, Germany, and Germantown, Maryland, January 9, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,500th [...]
Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
January 10, 2020
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents. The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of [...]
January 10, 2020
Vienna, Austria – The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS run. Each sample is identified by adding a unique index sequence to an NGS library, ensuring these libraries can be mixed and sequenced collectively. This system reduces sequencing costs [...]
January 10, 2020
Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the community oncology care setting Boulder, Colorado – ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including companion diagnostics for therapeutic selection, personalized [...]
January 10, 2020
ReadCoor’s technology simultaneously detects hundreds to thousands of RNA, DNA, proteins, and therapeutics in every cell within intact tissue Spatially surveying thousands of molecules simultaneously drives meaningful insights into disease states and treatment effects Spatial analysis across multiple omic formats gives researchers new insights into cancer, immuno-oncology, gene therapy, and neurodegenerative diseases CAMBRIDGE, Mass., January [...]
New Product: Hybrid confocal laser scanning microscope “OPTELICS® HYBRID+”
January 10, 2020
Lasertec Corporation today announced the release of OPTELICS® HYBRID+, the latest model of OPTELICS® HYBRID series confocal laser scanning microscope that combines two sets of optics - laser confocal and white light confocal - for the pursuit of high performance and multi-functions. OPTELICS® HYBRID+ will be presented to ELECTROTEST JAPAN from January 15, 2020 at Tokyo [...]
